메뉴 건너뛰기




Volumn 17, Issue 2, 2009, Pages 109-117

Bevacizumab (Avastin) in ocular processes other than choroidal neovascularization

Author keywords

Bevacizumab; Growth factor; Macular edema; Neovascularization; Vascular endothelial

Indexed keywords

ACETAZOLAMIDE; BEVACIZUMAB; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; TRIAMCINOLONE;

EID: 67749122395     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940802596534     Document Type: Review
Times cited : (4)

References (43)
  • 1
    • 33750337141 scopus 로고    scopus 로고
    • Available at
    • Avastin Drug Warning. 2005. Available at: http://www.fda. gov/medwatch/SAFETY/2005/Avastin-dearhcp.pdf
    • (2005) Avastin Drug Warning
  • 2
    • 33646440660 scopus 로고    scopus 로고
    • Testing intravitreal toxicity of bevacizumab (Avastin)
    • Manzano RP, Peyman GA, Khan P, et al. Testing intravitreal toxicity of bevacizumab (Avastin). Retina. 2006;26:257-261.
    • (2006) Retina , vol.26 , pp. 257-261
    • Manzano, R.P.1    Peyman, G.A.2    Khan, P.3
  • 3
    • 34247182509 scopus 로고    scopus 로고
    • Bevacizumab for neovascular ocular diseases
    • Review
    • Lynch SS, Cheng CM. Bevacizumab for neovascular ocular diseases. Ann Pharmacother. 2007;41:614-625. Review.
    • (2007) Ann Pharmacother , vol.41 , pp. 614-625
    • Lynch, S.S.1    Cheng, C.M.2
  • 4
    • 33750296920 scopus 로고    scopus 로고
    • The international intrav-itreal bevacizumab safety study: Using the internet to assess drug safety worldwide
    • Fung AE, Rosenfeld PJ, Reichel E. The international intrav-itreal bevacizumab safety study: using the internet to assess drug safety worldwide. Br J Ophthalmol. 2006;90:1344-1349.
    • (2006) Br J Ophthalmol , vol.90 , pp. 1344-1349
    • Fung, A.E.1    Rosenfeld, P.J.2    Reichel, E.3
  • 5
    • 0033856243 scopus 로고    scopus 로고
    • Expression of vascular en-dothelial growth factor and its receptors in inflamed and vascu-larized human corneas
    • Philipp W, Speicher L, Humpel C. Expression of vascular en-dothelial growth factor and its receptors in inflamed and vascu-larized human corneas. Invest Ophthalmol Vis Sci. 2000;41:2514-2522.
    • (2000) Invest Ophthalmol Vis Sci , vol.41 , pp. 2514-2522
    • Philipp, W.1    Speicher, L.2    Humpel, C.3
  • 6
    • 34247519047 scopus 로고    scopus 로고
    • Inhibition of experimental corneal neovascularization by bevacizumab (Avastin)
    • Manzano RP, Peyman GA, Khan P, et al. Inhibition of experimental corneal neovascularization by bevacizumab (Avastin). Br J Ophthalmol. 2007;91:804-807.
    • (2007) Br J Ophthalmol , vol.91 , pp. 804-807
    • Manzano, R.P.1    Peyman, G.A.2    Khan, P.3
  • 7
    • 34250315760 scopus 로고    scopus 로고
    • Topical bevacizumab therapy for corneal neovascularization
    • DeStafeno JJ, Kim T. Topical bevacizumab therapy for corneal neovascularization. Arch Ophthalmol. 2007;125:834-836.
    • (2007) Arch Ophthalmol , vol.125 , pp. 834-836
    • DeStafeno, J.J.1    Kim, T.2
  • 8
    • 34548722080 scopus 로고    scopus 로고
    • Subconjunctival bevacizumab for corneal neovascularization
    • Erdurmus M, Totan Y. Subconjunctival bevacizumab for corneal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2007;245:1577-1579.
    • (2007) Graefes Arch Clin Exp Ophthalmol , vol.245 , pp. 1577-1579
    • Erdurmus, M.1    Totan, Y.2
  • 9
    • 0031911115 scopus 로고    scopus 로고
    • Increased levels of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma
    • Tripathi RC, Li J, Tripathi BJ, et al. Increased levels of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998;105:232-237.
    • (1998) Ophthalmology , vol.105 , pp. 232-237
    • Tripathi, R.C.1    Li, J.2    Tripathi, B.J.3
  • 10
    • 33745392312 scopus 로고    scopus 로고
    • Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy
    • Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2006;142:155-158.
    • (2006) Am J Ophthalmol , vol.142 , pp. 155-158
    • Oshima, Y.1    Sakaguchi, H.2    Gomi, F.3    Tano, Y.4
  • 11
    • 33745413422 scopus 로고    scopus 로고
    • Intracameral bevacizumab for iris rubeosis
    • Grisanti S, Biester S, Peters S, et al. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol. 2006;142:158-160.
    • (2006) Am J Ophthalmol , vol.142 , pp. 158-160
    • Grisanti, S.1    Biester, S.2    Peters, S.3
  • 12
  • 14
    • 0033847918 scopus 로고    scopus 로고
    • Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity
    • Lashkari K, Hirose T, Yazdani J, et al. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol. 2000;156:1337-1344.
    • (2000) Am J Pathol , vol.156 , pp. 1337-1344
    • Lashkari, K.1    Hirose, T.2    Yazdani, J.3
  • 15
    • 67749132246 scopus 로고    scopus 로고
    • Bevacizumab for salvage treatment in threshold retinopathy of prematurity
    • Jan/Feb
    • Lalwani GA, Buch M, Cardone S, et al. Bevacizumab for salvage treatment in threshold retinopathy of prematurity. Retinal Physician. 2007; Jan/Feb: 77-78.
    • (2007) Retinal Physician , pp. 77-78
    • Lalwani, G.A.1    Buch, M.2    Cardone, S.3
  • 16
    • 34250766682 scopus 로고    scopus 로고
    • Intravitreal beva-cizumab in aggressive posterior retinopathy of prematurity
    • Travassos A, Teixeira S, Ferreira P, et al. Intravitreal beva-cizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging. 2007;38:233-237.
    • (2007) Ophthalmic Surg Lasers Imaging , vol.38 , pp. 233-237
    • Travassos, A.1    Teixeira, S.2    Ferreira, P.3
  • 17
    • 0027942607 scopus 로고
    • Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopa-thy and other retinal disorders
    • Aiello LP, Avery RL, Arrigg PG, et. Al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopa-thy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
    • (1994) N Engl J Med , vol.331 , pp. 1480-1487
    • Aiello, L.P.1    Avery, R.L.2    Arrigg, P.G.3    et., Al.4
  • 18
    • 0019473351 scopus 로고
    • Photocoag-ulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS), DRS
    • The Diabetic Retinopathy Study Research Group
    • The Diabetic Retinopathy Study Research Group. Photocoag-ulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS), DRS Report Number 8. Ophthalmology. 1981;88:583-600.
    • (1981) Ophthalmology , vol.88 , pp. 583-600
  • 19
    • 33646464279 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by virtre-ous hemorrhage
    • Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by virtre-ous hemorrhage. Retina. 2006;26:275-278.
    • (2006) Retina , vol.26 , pp. 275-278
    • Spaide, R.F.1    Fisher, Y.L.2
  • 20
    • 33747335983 scopus 로고    scopus 로고
    • Use of intravitreal bevacizumab as a preoper-ative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy
    • Chen E, Park C. Use of intravitreal bevacizumab as a preoper-ative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina. 2006;26:699-670.
    • (2006) Retina , vol.26 , pp. 699-670
    • Chen, E.1    Park, C.2
  • 21
    • 33748982649 scopus 로고    scopus 로고
    • Intravitreal beva-cizumab (Avastin) in the treatment of proliferative diabetic retinopathy
    • Avery RL, Pearlman J, Pieramici DL, et al. Intravitreal beva-cizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113:1695-1705.
    • (2006) Ophthalmology , vol.113 , pp. 1695-1705
    • Avery, R.L.1    Pearlman, J.2    Pieramici, D.L.3
  • 22
    • 67749113954 scopus 로고    scopus 로고
    • Panretinal photocoag-ulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study)
    • Nov epub ahead of print
    • Tonello M, Costa RA, Almeida FPP, et al. Panretinal photocoag-ulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol Scand. 2007 Nov (epub ahead of print).
    • (2007) Acta Ophthalmol Scand
    • Tonello, M.1    Costa, R.A.2    Almeida, F.P.P.3
  • 23
    • 0022347471 scopus 로고
    • Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Group
    • Early Treatment Diabetic Retinopathy Study Research Group
    • Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Group Report Number 1. Arch Ophthalmol. 1985;103:1796-1806.
    • (1985) Arch Ophthalmol , vol.103 , pp. 1796-1806
  • 24
    • 38349162286 scopus 로고    scopus 로고
    • Intravitreal triam-cinolone versus bevacizumab for refractory diabetic mac-ular oedema (IBEME study)
    • Paccola L, Costa RA, Folgosa MS, et al. Intravitreal triam-cinolone versus bevacizumab for refractory diabetic mac-ular oedema (IBEME study). Br J Ophthalmol. 2008;92:76-80.
    • (2008) Br J Ophthalmol , vol.92 , pp. 76-80
    • Paccola, L.1    Costa, R.A.2    Folgosa, M.S.3
  • 25
    • 34250774079 scopus 로고    scopus 로고
    • Beva-cizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes
    • Yanyali A, Aytug B, Horozoglu F, Nohutcu AF. Beva-cizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes. Am J Ophthalmol. 2007;144:124-126.
    • (2007) Am J Ophthalmol , vol.144 , pp. 124-126
    • Yanyali, A.1    Aytug, B.2    Horozoglu, F.3    Nohutcu, A.F.4
  • 26
    • 34748876124 scopus 로고    scopus 로고
    • A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema
    • Diabetic Retinopathy Clinical Research Network
    • Diabetic Retinopathy Clinical Research Network. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. 2007;114;1860-1867.
    • (2007) Ophthalmology , vol.114 , pp. 1860-1867
  • 27
    • 0034765032 scopus 로고    scopus 로고
    • Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema
    • Fine HF, Baffi J, Reed GF, et al. Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema. Am J Ophthalmol. 2001;132:794-796.
    • (2001) Am J Ophthalmol , vol.132 , pp. 794-796
    • Fine, H.F.1    Baffi, J.2    Reed, G.F.3
  • 28
    • 34250199569 scopus 로고    scopus 로고
    • Intravitreal beva-cizumab for treatment of uveitic macular edema
    • Coma MC, Sobrin L, Onal S, et al. Intravitreal beva-cizumab for treatment of uveitic macular edema. Ophthalmology. 2007;114:1574-1579.
    • (2007) Ophthalmology , vol.114 , pp. 1574-1579
    • Coma, M.C.1    Sobrin, L.2    Onal, S.3
  • 29
    • 38049123471 scopus 로고    scopus 로고
    • Intravitreal beva-cizumab (Avastin) as a treatment for refractory macular edema in patients with uveitis: A pilot study
    • Mackensen F, Heinz C, Becker M, et al. Intravitreal beva-cizumab (Avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study. Retina. 2008;28:41-45.
    • (2008) Retina , vol.28 , pp. 41-45
    • Mackensen, F.1    Heinz, C.2    Becker, M.3
  • 30
    • 0036970074 scopus 로고    scopus 로고
    • Correlation of increased vascular endothelial growth factor with neovasculariza-tion and permeability in ischemic central retinal vein occlusion
    • Boyd SR, Zachary I, Chakravarthy U, et al. Correlation of increased vascular endothelial growth factor with neovasculariza-tion and permeability in ischemic central retinal vein occlusion. Arch Ophthalmol. 2002;120:1644-1650.
    • (2002) Arch Ophthalmol , vol.120 , pp. 1644-1650
    • Boyd, S.R.1    Zachary, I.2    Chakravarthy, U.3
  • 31
    • 37349107798 scopus 로고    scopus 로고
    • Intravitreal be-vacizumab injections for treatment of central retinal vein occlusion: Six-month results of a prospective trial
    • Priglinger SG, Wolf AH, Kreutzer TC, et al. Intravitreal be-vacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina. 2007;27:1004-1012.
    • (2007) Retina , vol.27 , pp. 1004-1012
    • Priglinger, S.G.1    Wolf, A.H.2    Kreutzer, T.C.3
  • 32
    • 36248981014 scopus 로고    scopus 로고
    • Early bevacizumab treatment of central retinal vein occlusion
    • Ferrara DC, Koizumi H, Spaide RF, et al. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol. 2007;144:864-871.
    • (2007) Am J Ophthalmol , vol.144 , pp. 864-871
    • Ferrara, D.C.1    Koizumi, H.2    Spaide, R.F.3
  • 33
    • 37349040676 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) in central retinal vein occlusion
    • Hsu J, Kaiser RS, Sivalingam A, et al. Intravitreal bevacizumab (Avastin) in central retinal vein occlusion. Retina. 2007;27:1013-1019.
    • (2007) Retina , vol.27 , pp. 1013-1019
    • Hsu, J.1    Kaiser, R.S.2    Sivalingam, A.3
  • 34
    • 23744502535 scopus 로고    scopus 로고
    • Pathogenesisofmacular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6
    • NomaH,FunatsuH,YamasakiM,etal.Pathogenesisofmacular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140:256-261.
    • (2005) Am J Ophthalmol , vol.140 , pp. 256-261
    • Noma, H.1    Funatsu, H.2    Yamasaki, M.3
  • 35
    • 34247231034 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion
    • Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007;27:419-425.
    • (2007) Retina , vol.27 , pp. 419-425
    • Rabena, M.D.1    Pieramici, D.J.2    Castellarin, A.A.3
  • 36
    • 40549120630 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for the treatmentof macular oedema secondary to branch retinal vein occlusion
    • Kreutzer TC, Alge CS, Wolf AH, et al. Intravitreal bevacizumab for the treatmentof macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol. 2008;92:351-355.
    • (2008) Br J Ophthalmol , vol.92 , pp. 351-355
    • Kreutzer, T.C.1    Alge, C.S.2    Wolf, A.H.3
  • 37
    • 34250343012 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor be-vacizumab (avastin) for radiation retinopathy
    • Finger PT, Chin K. Anti-vascular endothelial growth factor be-vacizumab (avastin) for radiation retinopathy. Arch Ophthalmol. 2007;125:751-756.
    • (2007) Arch Ophthalmol , vol.125 , pp. 751-756
    • Finger, P.T.1    Chin, K.2
  • 38
    • 34748830341 scopus 로고    scopus 로고
    • Intravitreal be-vacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma
    • Mason JO III, Albert MA Jr, Persaud, TO, et al. Intravitreal be-vacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma. Retina. 2007;27:903-907.
    • (2007) Retina , vol.27 , pp. 903-907
    • Mason III, J.O.1    Albert Jr, M.A.2    Persaud, T.O.3
  • 39
    • 36448946551 scopus 로고    scopus 로고
    • Primary intravit-real bevacizumab for the management of pseudophakic cystoid macular edema: Pilot study of the Pan-American Collaborative Retina Study Group
    • Arevalo JF, Garcia-Amaris RA, Roca JA, et al. Primary intravit-real bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group. J Cataract Refract Surg. 2007;33:2098-2105.
    • (2007) J Cataract Refract Surg , vol.33 , pp. 2098-2105
    • Arevalo, J.F.1    Garcia-Amaris, R.A.2    Roca, J.A.3
  • 40
    • 37349096559 scopus 로고    scopus 로고
    • Efficacy of in-travitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema
    • Spitzer MS, Ziemssen F, Yoeruek E, et al. Efficacy of in-travitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg. 2008;34:70-75.
    • (2008) J Cataract Refract Surg , vol.34 , pp. 70-75
    • Spitzer, M.S.1    Ziemssen, F.2    Yoeruek, E.3
  • 41
    • 34548205365 scopus 로고    scopus 로고
    • Findings in fluorescein angiography and optical coherence tomography after intravit-real bevacizumab in type 2 idiopathic macular telangiectasia
    • Issa PC, Holz FG, Scholl HPN, et al. Findings in fluorescein angiography and optical coherence tomography after intravit-real bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology. 2007;114:1736-1742.
    • (2007) Ophthalmology , vol.114 , pp. 1736-1742
    • Issa, P.C.1    Holz, F.G.2    Scholl, H.P.N.3
  • 42
    • 34250782794 scopus 로고    scopus 로고
    • Intravitreal beva-cizumab (Avastin) injection in ocular ischemic syndrome
    • Amselem L, Montero J, Diaz-Llopis M, et al. Intravitreal beva-cizumab (Avastin) injection in ocular ischemic syndrome. Am J Ophthalmol. 2007;144:122-124.
    • (2007) Am J Ophthalmol , vol.144 , pp. 122-124
    • Amselem, L.1    Montero, J.2    Diaz-Llopis, M.3
  • 43
    • 34548032578 scopus 로고    scopus 로고
    • Intravitreal injection of beva-cizumab for cystoid macular edema in retinitis pigmentosa
    • Melo GB, Farah ME, Aggio FB. Intravitreal injection of beva-cizumab for cystoid macular edema in retinitis pigmentosa. Acta Ophthalmol Scand. 2007;85:461-463.
    • (2007) Acta Ophthalmol Scand , vol.85 , pp. 461-463
    • Melo, G.B.1    Farah, M.E.2    Aggio, F.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.